# Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates

> **NCT01427686** · PHASE4 · UNKNOWN · sponsor: **University of Ulm** · enrollment: 20 (estimated)

## Conditions studied

- Arterial Hypotension

## Interventions

- **DRUG:** Dobutamine
- **DRUG:** Dopamine

## Key facts

- **NCT ID:** NCT01427686
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2015-02
- **Final completion:** 2016-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01427686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01427686, "Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01427686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*